Antithrombotic therapy in complex percutaneous coronary intervention patients requiring chronic anticoagulation

0Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

The optimal antithrombotic treatment in patients receiving oral anticoagulation undergoing percutaneous coronary intervention (PCI) has been a field of intensive research. Although triple antithrombotic therapy had been, until lately, the strategy of choice, recent evidence points to the superiority of dual antithrombotic therapy regarding bleeding prevention, without significantly compromising efficacy. In the further challenging scenario of complex PCI, associated with a higher ischemic risk, the efficacy of an aspirin-free strategy, adopted shortly after the index event is under question, rendering decision-making a fairly difficult scenario for clinicians. Since patients with an indication for oral anticoagulation undergoing complex PCI are underrepresented in randomized trials, there are scarce data regarding the optimal treatment strategy in such patients. This review aims to analyze and compare different approaches regarding the type and duration of antithrombotic regimens, focusing on both safety and efficacy outcomes, as well as to discuss recent guidelines' suggestions regarding the therapeutic approach in patients receiving oral anticoagulation undergoing PCI procedures of increased complexity.

Cite

CITATION STYLE

APA

Benetou, D. R., Vlachakis, P. K., Varlamos, C., & Alexopoulos, D. (2021). Antithrombotic therapy in complex percutaneous coronary intervention patients requiring chronic anticoagulation. US Cardiology Review, 15. https://doi.org/10.15420/usc.2020.31

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free